Skip to main content
UO

Uh-Oh

Uh-Oh Labs provides health diagnostics and COVID-19 testing services utilizing PCR and antigen testing methodologies to deliver accurate results. The lab addresses the need for timely and reliable health assessments in the context of ongoing public health challenges.

Santa Clara, CubaFounded 201813700+ followers
Updated 19 months ago

Funding

$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

UV
Funding rounds are not available yet.

Founders

Product

Problem

Current COVID-19 testing methods can be slow, expensive, and sometimes lack the accuracy needed for timely and effective infection control in workplaces and healthcare settings. Rapid antigen tests offer quick results but may miss active infections, while PCR tests are accurate but can take hours or days to process, delaying critical decisions.

Solution

Uh-Oh Labs provides an ultra-portable, PCR-quality molecular diagnostic platform for rapid and accurate COVID-19 testing at the point of care. The UOL COVID-19 Test system utilizes Loop-de-Loop™ RT-LAMP technology to deliver results in as fast as 12 minutes with 96.1% accuracy, comparable to high-sensitivity PCR tests. The system includes a reusable instrument, single-use test kits, and a mobile iOS app for clear result interpretation and integration with other systems. This enables businesses and healthcare providers to quickly identify infected individuals, ensure a safe environment, and plan for workforce needs with confidence.

Target Audience

The primary target audience includes businesses, healthcare providers, and point-of-care facilities seeking rapid, accurate, and affordable COVID-19 testing solutions for employees, patients, and staff.

Features

  • Loop-de-Loop™ RT-LAMP chemistry for PCR-quality results without complex equipment
  • Rapid detection of positive samples in as little as 12 minutes, negative results in 40 minutes
  • High accuracy (96.1%) with no false positives compared to highly-sensitive PCR tests
  • Analytical sensitivity over 20,000x higher than some commercially-available rapid antigen tests
  • Simple workflow: anterior nasal swab sample collection and test setup in under 5 minutes
  • UOL DxPro iOS app for automated data interpretation and clear-text results
  • Connectivity for patient registration, SMS result delivery, and automated reporting
  • Portable instrument powered via USB-C connection
This profile is AI-generated and may contain inaccuracies.